| Not Yet Recruiting | Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-bas Atrial Fibrillation (AF) | — | 2025-05-01 |
| Terminated | Safety and Efficacy of Pulsed-field Ablation for Atrial Fibrillation in High Versus Low-volume Ablation Center Atrial Fibrillation | — | 2024-08-29 |
| Unknown | Post-ablation Alcohol Impacts Arrhythmia Recurrence, Quality of Life and Cognition in AF Atrial Fibrillation | N/A | 2022-08-22 |
| Unknown | Natural History of COVID-19-Related Atrial Fibrillation COVID-19, Atrial Fibrillation New Onset | N/A | 2021-04-15 |
| Unknown | RF Applications for Residual LAA Leaks Left Atrial Appendage Thrombosis, Stroke, Ischemic, Atrial Fibrillation | N/A | 2021-02-01 |
| Unknown | Immune Response Following COVID-19 Vaccination IgM and IgG in Blood | — | 2021-01-15 |
| Unknown | Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function Covid19 | — | 2020-08-20 |
| Unknown | Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Le Device-Related Thrombosis, Atrial Fibrillation, Left Atrial Appendage Occlusion | Phase 4 | 2020-08-05 |
| Withdrawn | Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare COVID-19 | N/A | 2020-06-01 |
| Unknown | Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) COVID-19 | Phase 1 | 2020-05-08 |
| Unknown | ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines Covid19 | — | 2020-03-27 |
| Unknown | Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation Thromboembolic Events | — | 2019-10-01 |
| Suspended | Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation Ventricular Arrythmia | N/A | 2018-05-16 |
| Completed | Half-normal Saline in Atrial Fibrillation Ablation Atrial Fibrillation | N/A | 2018-05-02 |
| Unknown | Transcatheter Leak Closure With Detachable Coils Following Incomplete Left Atrial Appendage Closure Procedures Left Atrial Appendage Incomplete Closure | N/A | 2018-04-09 |
| Unknown | Impact of Anxiety on Cardiac Substrate Modification in Women With Atrial Fibrillation Undergoing Catheter Abla Atrial Fibrillation | N/A | 2015-09-01 |
| Unknown | Impact of Life-Style Modification On Ablation Outcome in Atrial Fibrillation Atrial Fibrillation, Obesity | — | 2014-08-01 |
| Completed | Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ablati Atrial Fibrillation | — | 2014-07-01 |
| Unknown | Cognitive Impairment in Atrial Fibrillation Atrial Fibrillation, Mild Cognitive Impairment, Dementia | — | 2014-07-01 |
| Completed | Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation Atrial Fibrillation | Phase 3 | 2014-04-01 |
| Unknown | PV Reconnection After PVAI at Different Power Settings and Adenosine Provocation Paroxysmal Atrial Fibrillation | Phase 3 | 2013-05-01 |
| Unknown | Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrenc Persistent Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation | N/A | 2013-02-01 |
| Completed | Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF) Atrial Fibrillation | — | 2012-12-01 |
| Completed | Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Atrial Fibrillation | N/A | 2012-07-01 |
| Unknown | Does Atrial Fibrillation (AF) Termination Without Additional Ablation Influence Outcome? Atrial Fibrillation | — | 2012-05-01 |
| Completed | Impact Of Different Ablation Approaches on Outcome In Coexistent Atrial Fibrillation and Flutter Atrial Arrhythmia, Quality of Life | Phase 3 | 2011-09-01 |
| Completed | Effect of Catheter Ablation on Clinical Course of Migraine in AF Patients With or Without Previous History of Migraine, Atrial Fibrillation | Phase 3 | 2010-12-01 |
| Completed | Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent Persistent Atrial Fibrillation | Phase 3 | 2010-11-01 |
| Completed | Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmo Atrial Fibrillation | Phase 3 | 2010-10-01 |
| Completed | The Role of Cardiac Biomarkers in Prediction of Outcome in Atrial Fibrillation Patients Undergoing Catheter Ab Atrial Fibrillation | — | 2010-06-01 |
| Completed | Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes Atrial Fibrillation, Perimitral Flutter | Phase 3 | 2010-03-01 |
| Completed | Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablati Thromboembolism | Phase 3 | 2010-01-01 |
| Unknown | Impact of the Pulmonary Vein Isolation on Exercise Capacity in Patients With Chronic Atrial Fibrillation Chronic Atrial Fibrillation | — | 2010-01-01 |
| Completed | Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Ra Ventricular Tachycardia | Phase 3 | 2010-01-01 |
| Completed | Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD Heart Failure | Phase 4 | 2008-10-01 |